rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Timothy Schmid

EVP, WW Chair, MedTech

Company insider

Files Form 4 as: EVP, WW Chair, MedTech, Johnson & Johnson.

Every Form 4 they filed

In numbers

Trades disclosed
89
Buys
0
Sells
4
Bought
$0
Sold
$30.2M
Companies
1
Companies where not an officer
0
First trade
8 Feb 2024
Last trade
2 Sep 2026
Last filed
4 Sep 2026

Companies traded

Where they are an officer
JNJ Johnson & JohnsonOfficer · Pharmaceuticals · last 2 Sep 20260 buys · 4 sells

Activity over time

1 Feb 2025 – 1 Oct 2026
20Feb 25Jul 25Dec 25May 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Code M$1.5M11,070 at $131.94filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$3.0M11,070 at $274.74filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Code M$3.4M22,527 at $151.41filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—11,070 at $0.00filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—22,527 at $0.00filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$6.2M22,527 at $274.74filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—11,070 at $0.00filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—22,527 at $0.00filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Code M$1.5M11,070 at $131.94filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$3.0M11,070 at $274.74filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Code M$3.4M22,527 at $151.41filing
2 Sep 2026filed 4 Sep 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$6.2M22,527 at $274.74filing
20 Feb 2026filed 23 Feb 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$325K1,322 at $245.66filing
20 Feb 2026filed 23 Feb 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$325K1,322 at $245.66filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$3.3M13,625 at $244.20filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Code M$1.2M8,998 at $129.51filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & JohnsonPharmaceuticalsSEC FORM 4 Sold$2.2M8,998 at $244.53filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—13,625 at $0.00filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—8,998 at $0.00filing
18 Feb 2026filed 18 Feb 2026JNJ Johnson & Johnsonoption or derivative · PharmaceuticalsSEC FORM 4 Code M—13,625 at $0.00filing

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Daniel E. PintoDirector · Director at Johnson & Johnson, filing Form 4 there in the last year
Marillyn A. HewsonDirector · Director at Johnson & Johnson, filing Form 4 there in the last year
Eugene A. WoodsDirector · Director at Johnson & Johnson, filing Form 4 there in the last year
Jennifer L. TaubertDirector · EVP, WWC. Innovative Medicine at Johnson & Johnson, filing Form 4 there in the last year
Joaquin DuatoCEO and Chairman of the Board · CEO and Chairman of the Board at Johnson & Johnson, filing Form 4 there in the last year
Lloyd DoggettRepresentative, TX-37 · Also traded JNJ in the last 90 days
Ro KhannaRepresentative, CA-17 · Also traded JNJ in the last 90 days
Thomas H. Kean, Jr.Representative, NJ-07 · Also traded JNJ in the last 90 days